首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4412篇
  免费   318篇
  国内免费   23篇
耳鼻咽喉   43篇
儿科学   89篇
妇产科学   84篇
基础医学   606篇
口腔科学   39篇
临床医学   541篇
内科学   897篇
皮肤病学   65篇
神经病学   535篇
特种医学   142篇
外国民族医学   2篇
外科学   771篇
综合类   37篇
一般理论   1篇
预防医学   253篇
眼科学   31篇
药学   380篇
中国医学   6篇
肿瘤学   231篇
  2023年   25篇
  2022年   38篇
  2021年   133篇
  2020年   87篇
  2019年   117篇
  2018年   142篇
  2017年   111篇
  2016年   128篇
  2015年   126篇
  2014年   163篇
  2013年   221篇
  2012年   339篇
  2011年   330篇
  2010年   195篇
  2009年   156篇
  2008年   247篇
  2007年   261篇
  2006年   220篇
  2005年   234篇
  2004年   212篇
  2003年   193篇
  2002年   179篇
  2001年   76篇
  2000年   71篇
  1999年   63篇
  1998年   44篇
  1997年   22篇
  1996年   29篇
  1995年   17篇
  1994年   21篇
  1993年   19篇
  1992年   37篇
  1991年   31篇
  1990年   40篇
  1989年   39篇
  1988年   36篇
  1987年   43篇
  1986年   31篇
  1985年   35篇
  1984年   34篇
  1983年   17篇
  1982年   13篇
  1979年   24篇
  1978年   11篇
  1974年   18篇
  1973年   16篇
  1971年   10篇
  1970年   13篇
  1969年   9篇
  1966年   8篇
排序方式: 共有4753条查询结果,搜索用时 171 毫秒
101.
A systematic approach to the synthesis of organocatalyzed oligo(d,l-lactide) demonstrates that choice of initiator, catalytic ratio, and reaction time yields well-controlled oligomers. Ring-opening polymerization of d,l-lactide with the initiator α-methyl propargyl alcohol, a secondary alcohol, used in excess of 4-dimethylaminopyridine catalyst mitigates cyclicization, transesterification, and catalyst-initiated side reactions. This approach enables the design of uniform lactide oligomers for controlled release applications, such as delivery systems for drugs, prodrugs, and molecular sensors.

A systematic approach to the synthesis of organocatalyzed oligo(d,l-lactide) demonstrates that choice of initiator, catalytic ratio, and reaction time yields well-controlled oligomers.

Poly(lactide) (PLA) is a versatile polymer with properties suitable for a range of controlled release applications. Molecular weight and copolymer composition control degradation and drug release, with degradation yielding biocompatible lactic acid products. PLA and copolymers of lactide and glycolide (PLGA) have been used pre-clinically and clinically for release of drugs,1–3 prodrugs,4–6 and molecular sensors.7–9 Highly reproducible PLA chemistries are particularly important to ensure control over the release of drugs with narrow therapeutic windows and to enhance efficacy by reducing dependence on patient compliance.10–13 Stannous octoate is commonly employed as an organometallic catalyst of lactide ring-opening polymerization (ROP).14,15 However, tin catalysts, which are challenging to fully remove during purification, can result in toxicity.16 Alternatives such as strongly basic amine organocatalysts are favored, particularly 4-dimethylaminopyridine (DMAP), which was pioneered by Nederberg et al.17 DMAP-mediated ROP is used for one-pot PLA polymerizations and conjugations,18 diblock or triblock copolymerizations with lactide as a first or second block,19–21 grafting lactide to cellulose polymer fibers,22 and synthesizing star-shaped/cross-linked PLA networks.23 PLA has also been exploited to tether and release drugs from linear polymers and hydrogel depots.24 Drug tethers are typically low molecular weight oligo(lactide) composed of fewer than seven lactide repeat units to avoid crystallinity and associated challenges with solubility and control over degradation rates.25 Self-catalysis, or direct polycondensation, of lactic acid at increased temperature and reduced pressure for an extended time yields low-molecular weight (800–3200 Da) oligo(lactide), in contrast to organocatalysts that are commonly employed for high molecular weight PLA synthesis. However, extensive setup and environmental control decrease the accessibility of these reactions.26,27 Furthermore, with neither an initiator nor a catalyst used in polycondensation, mixtures of α-hydroxy and ω-carboxy PLA are formed, limiting the versatility of post-polymerization drug functionalization.28 Alternatively, click chemistry29 may be exploited to control subsequent modification of oligo(lactide) by employing a ‘clickable’ alcohol to initiate oligo(lactide) synthesis.30Here, we explored bulk ROP of d,l-lactide by propargyl alcohol initiator and DMAP catalyst to synthesize low molecular weight oligo(lactide) linkers. To enable subsequent click reactions and to mitigate crystallinity, propargyl alcohol (PA) and d,l-lactide (L) were used.27 Although not studied here, similar approaches have shown products do not epimerize, and we expect oligomers to be atactic and amorphous.17 To investigate the molecular weight and polydispersity of oligo(lactide), an initial polymerization was designed similar to that of Nederberg et al.17 and Coulembier and Dubois18 using a PA : L : DMAP ratio of 1 : 20 : 4 (Scheme 1; see Table S1, ESI). The neat polymerization was stirred at 130 °C under a nitrogen environment. After 5, 10, 15, 30, and 60 minutes, reaction vials were opened to atmosphere and cooled before dissolution in dichloromethane (DCM) and precipitation in hexanes. 1H-NMR spectroscopy identified successful synthesis of PA-functional oligo(d,l-lactide) (PA-ODLA) with ∼99% conversion of d,l-lactide after only 5 minutes of polymerization (Fig. 1a; see Fig. S3, ESI). Integration of peaks C, E, and F indicated linkers were ∼19 lactide units, or an average Mn of 2825 Da. However, matrix assisted laser desorption ionization time of flight mass spectrometry suggested Mn was 752 Da. As Mn determined by NMR was based on average end-group analysis and assumed PA-initiated oligo(lactide), and Mn determined by MALDI analysis represented all species present, these data indicated that not all oligo(lactide) chains were initiated by PA. Rather, distinct series of peaks periodically separated by 144 Da, the Mn of lactide, were formed during polymerization (α, β, γ, δ, ε, and ζ; Fig. 1b; see Table S2, ESI). Peaks 72 Da less than these peaks were also identified (α′–ζ′). Additional reactions were conducted to identify the formed products: one with the initiator α-methyl propargyl alcohol (αMPA; see Fig. S4, ESI), and another with only d,l-lactide and DMAP but no initiator (see Fig. S9, ESI).Open in a separate windowScheme 1Ring-opening polymerization of lactide by alcohol initiator. X = H, propargyl alcohol; CH3, α-methyl propargyl alcohol.Open in a separate windowFig. 1Five minute polymerizations of 1 : 20 : 4 propargyl alcohol : lactide : 4-dimethylaminopyridine form varied products. (a) 1H-NMR, with hydrogen peaks assignments shown. (b) MALDI-TOF, where colors represent peak sets that repeat every 72 Da and the inset shows a full 144 Da peak set.The desired product, PA-ODLA “α” (Fig. 1a), was formed via DMAP base activation of PA, which initiated ROP (see Fig. S5, ESI). Base activation of the alcohol was confirmed similar to previous reports20,31 using 1H-NMR of PA mixed with DMAP in CDCl3 to identify ppm shifts for hydroxyl groups (see Fig. S6, ESI). Peak α′, 72 Da less than α, was the result of transesterification of PA-ODLA (see Fig. S7, ESI), which is a common side-reaction during ROP of lactide.18,20 Two undesired products, peaks ζ and ζ′, were cyclic PA-ODLA with and without transesterification, respectively. Cyclicization increases over time during ROP of lactide32–34 and is undesired because hydroxyl end groups are not available for subsequent conjugation. These peaks were due to radical-mediated dehydration with hydroxyl end group participation,35 as the addition of hydroquinone (HQ), a radical scavenger, eliminated peaks ζ and ζ′ (see Fig. S8, ESI). However, a peak appeared that corresponded to HQ-DMAP-ODLA and lacked alkyne functionalities for subsequent click reactions.Another undesired product, DMAP-ODLA, or peak γ, formed via DMAP nucleophilic attack of lactide (see Fig. S9, ESI). Peak γ′, separated by 72 Da from peak γ, resulted from transesterification of DMAP-ODLA. By conducting reactions of only DMAP and lactide, only PA and lactide, and only αMPA and lactide, it was confirmed that DMAP can both initiate and catalyze lactide ROP, but PA and αMPA cannot (see Fig. S10, ESI). DMAP-ODLA formed due to PA : DMAP ratios less than 1, as previously described,18 and is undesired because ‘clickable’ propargyl end groups are not present. Finally, peaks β, δ, and ε are likely ion fragments, as these peaks were only present when using MALDI in linear, but not reflector, mode (see Fig. S11, ESI).To increase the amount of oligo(lactide) with alkyne and hydroxyl functionalities, side reactions were systematically addressed. It was noted that transesterification increased with time of polymerization and was greater for PA than for αMPA, as less nucleophilic secondary alcohols are unable to participate in transesterification reactions.30 Thus, reactions were conducted at 130 °C for 5 minutes using αMPA as the initiator to optimize desired product (αMPA-ODLA, peak α).Ratios of αMPA : L : DMAP were investigated to mitigate undesired DMAP-initiated and cyclic ODLA (Fig. 2a; see Fig. S12, ESI). Increasing αMPA : L at a constant αMPA : DMAP increased the intensity of α relative to both ζ and γ (Fig. 2b; see Fig. S13, ESI). Similar behavior was identified when holding L : DMAP constant and increasing αMPA : L (Fig. 2c; see Fig. S14, ESI). These results suggest that αMPA : L controls cyclicization, as the distribution of ζ is similar among reactions in Fig. 2a, and the ratio of ζ : α decreases between ratios of 1 : 10 and 1 : 2 in Fig. 2b. αMPA : DMAP controls DMAP-ODLA generation, as the distribution of γ is similar within Fig. 2b and smallest at a ratio of 2 : 1. Finally, lower ratios of L : DMAP appear to increase α, with 2 : 1 yielding the greatest amount of desired product α. Altogether, higher αMPA : L, higher αMPA : DMAP, and lower L : DMAP ratios yield higher levels of α relative to γ and ζ.Characterization of 5 minute αMPA polymerizations. X = % conversion, Mn = molecular weight, PDI = polydispersity
αMPA : L : DMAP X M n (NMR) M n (MALDI)PDI
1 : 20 : 496%2040 Da721 Da1.16
1 : 20 : 287%3620 Da782 Da1.20
1 : 20 : 188%3150 Da826 Da1.23
1 : 20 : 0.565%3120 Da881 Da1.23
1 : 10 : 192%2200 Da759 Da1.25
1 : 5 : 197%1470 Da763 Da1.16
1 : 2 : 197%1160 Da656 Da1.10
1 : 10 : 596%2050 Da772 Da1.11
1 : 5 : 2.597%1550 Da725 Da1.12
Open in a separate windowOpen in a separate windowFig. 2Initiator, catalyst, and monomer relationships control ratios of formed products. (a) MALDI-TOF with (top to bottom) increasing αMPA : DMAP and L : DMAP. (b) MALDI-TOF with increasing αMPA : L and decreasing L : DMAP. (c) MALDI-TOF with increasing αMPA : DMAP and αMPA : L. *β is a temporary ion fragment (see Fig. 1).Increasing the stoichiometry of lactide to initiator is commonly exploited to form linkers of various lengths to achieve differential release rates.24 To explore the utility of this approach using optimized reaction conditions, αMPA : L ratios of 1 : 2, 1 : 5, and 1 : 10 were investigated using 1 mol% DMAP (). With an αMPA : DMAP ratio of 33 or greater, γ was absent in all reactions. The polymerization with the highest αMPA : L ratio, 1 : 2 : 0.03, had the greatest overall α : ζ ratio. Interestingly, the peak η appeared, corresponding to αMPA-ODLA with a K+ ion, in contrast to α with a DMAP-H+ ion adduct. There was a transition from η to α over time, and η was most abundant in 1 : 2 : 0.03 reactions. This was explored further with polymerization times of 4 minutes and less (see Fig. S18, ESI). One minute reactions showed negligible conversion of lactide monomer. After 2 minutes, conversion was 68% and the major product was η. By 4 minutes, α and ζ exceeded η, suggesting that shorter reaction times are necessary to isolate linear αMPA-ODLA without DMAP adducts.Characterization of αMPA-initiated reactions of various stoichiometry and reaction times. X = % conversion, Mn = molecular weight
αMPA : L : DMAPTime X α : ζ M n (MALDI)
1 : 2 : 0.035 min82%1.1619 Da
10 min99%1.3685 Da
15 min99%1.6661 Da
1 : 5 : 0.065 min73%0.13753 Da
10 min89%0.23727 Da
15 min94%0.24758 Da
1 : 10 : 0.115 min32%0.25772 Da
10 min71%0.10736 Da
15 min83%0.08747 Da
Open in a separate windowFinally, proof of concept conjugations demonstrated the utility of αMPA-ODLA as a heterobifunctional linker (Fig. 3; see Fig. S19, ESI). Following 90 seconds of polymerization of 1 : 2 : 0.03 αMPA : L : DMAP (Fig. 3a), αMPA-ODLA was modified on either propargyl or hydroxyl end groups. 3-Azido-1-propanol (see Fig. S20, ESI) was added to propargyl moieties via Huisgen 1,3-dipolar cycloaddition (Fig. 3b). Interestingly, only η was shifted by 101 Da, the Mn of 3-azido-1-propanol, by MALDI analysis, suggesting that DMAP adducts in α interfere with propargyl modification. Hydroxyl end groups were modified to carboxylic acids using two-step, one-pot reactions whereby succinic anhydride (SA) was added following 90 seconds of lactide polymerization (Fig. 3c). These reactions were viable in either order when modifying both ends of αMPA-ODLA (Fig. 3d, S19d and e, see ESI). It is noted that since an alcohol was used as a model azide, both N3-αMPA-ODLA-SA and SA-N3-αMPA-ODLA-SA formed during reactions. Pure N3-αMPA-ODLA-SA could be achieved by forming αMPA-ODLA-SA, removing unreacted SA, and conducting azide–alkyne conjugation.Open in a separate windowFig. 3Demonstration of αMPA-ODLA linker heterobifunctionality using MALDI-TOF analysis. (a) Polymerization to form αMPA-ODLA. (b) Reaction to open succinic anhydride (SA) on αMPA-ODLA. (c) Reaction to add 3-azido-1-propanol (N3) on αMPA-ODLA. (d) Reaction to add 3-azido-1-propanol on αMPA-ODLA-SA. (e) Chemical structures of αMPA-ODLA: blue, αMPA-ODLA-SA: grey, N3-αMPA-ODLA: purple, N3-αMPA-ODLA-SA: teal, SA-N3-αMPA-ODLA-SA: pink.  相似文献   
102.
103.
104.
Zhou  John  Benoit  Marc  Sharoar  Md Golam 《Metabolic brain disease》2022,37(6):1703-1725
Metabolic Brain Disease - Alzheimer’s disease (AD) is the most common dementia with currently no known cures or disease modifying treatments (DMTs), despite much time and effort from the...  相似文献   
105.

Background

Lipoprotein(a) [Lp(a)], a major carrier of oxidized phospholipids (OxPL), is associated with an increased incidence of aortic stenosis (AS). However, it remains unclear whether elevated Lp(a) and OxPL drive disease progression and are therefore targets for therapeutic intervention.

Objectives

This study investigated whether Lp(a) and OxPL on apolipoprotein B-100 (OxPL-apoB) levels are associated with disease activity, disease progression, and clinical events in AS patients, along with the mechanisms underlying any associations.

Methods

This study combined 2 prospective cohorts and measured Lp(a) and OxPL-apoB levels in patients with AS (Vmax >2.0 m/s), who underwent baseline 18F-sodium fluoride (18F-NaF) positron emission tomography (PET), repeat computed tomography calcium scoring, and repeat echocardiography. In vitro studies investigated the effects of Lp(a) and OxPL on valvular interstitial cells.

Results

Overall, 145 patients were studied (68% men; age 70.3 ± 9.9 years). On baseline positron emission tomography, patients in the top Lp(a) tertile had increased valve calcification activity compared with those in lower tertiles (n = 79; 18F-NaF tissue-to-background ratio of the most diseased segment: 2.16 vs. 1.97; p = 0.043). During follow-up, patients in the top Lp(a) tertile had increased progression of valvular computed tomography calcium score (n = 51; 309 AU/year [interquartile range: 142 to 483 AU/year] vs. 93 AU/year [interquartile range: 56 to 296 AU/year; p = 0.015), faster hemodynamic progression on echocardiography (n = 129; 0.23 ± 0.20 m/s/year vs. 0.14 ± 0.20 m/s/year] p = 0.019), and increased risk for aortic valve replacement and death (n = 145; hazard ratio: 1.87; 95% CI: 1.13 to 3.08; p = 0.014), compared with lower tertiles. Similar results were noted with OxPL-apoB. In vitro, Lp(a) induced osteogenic differentiation of valvular interstitial cells, mediated by OxPL and inhibited with the E06 monoclonal antibody against OxPL.

Conclusions

In patients with AS, Lp(a) and OxPL drive valve calcification and disease progression. These findings suggest lowering Lp(a) or inactivating OxPL may slow AS progression and provide a rationale for clinical trials to test this hypothesis.  相似文献   
106.
107.
Recent evidence suggests that opening of mitochondrial KATP channels in cardiac muscle triggers the preconditioning phenomenon through free radical production. The present study tested the effects of KATP channel openers in a vascular smooth muscle cell model using the fluorescent probe MitoTracker (MTR) Red™ for detection of reactive oxygen species (ROS). Rat aortic smooth muscle cells (A7r5) were incubated with 1 μM reduced MTR (non-fluorescent) and the MTR oxidation product (fluorescent) was quantified. Thirty-minute pretreatment with either diazoxide (200 μM) or pinacidil (100 μM), both potent mitochondrial KATP channel openers, increased fluorescent intensity (FI) to 149 and 162 % of control (p < 0.05 for both), respectively, and the KATP channel inhibitor 5-hydroxydecanoate (5HD) blocked it. Valinomycin, a potassium-selective ionophore, raised FI to 156 % of control (p <: 0.05). However, 5HD did not affect the valinomycin-induced increase in FI. Inhibition of mitochondrial electron transport (myxothiazol) or uncoupling of oxidative phosphorylation (dinitrophenol) also blocked either valinomycin- or diazoxide-induced increase in FI, and free radical scavengers prevented any diazoxide-mediated increase in fluorescence. Finally the diazoxide-induced increase in fluorescence was not blocked by the PKC inhibitor chelerythrine, but was by HMR 1883, a putative surface KATP channel blocker. Thus opening of KATP channels increases generation of ROS via the mitochondrial electron transport chain in vascular smooth muscle cells. Furthermore, a potassium-selective ionophore can mimic the effect of putative mitochondrial KATP channel openers. We conclude that potassium movement through KATP directly leads to ROS production by the mitochondria. Received: 7 January 2002, Returned for revision: 31 January 2002, Revision received: 21 February 2002, Accepted: 14 March 2002  相似文献   
108.

Background and aims

Lynch syndrome (LS) is associated with an increased risk of small bowel tumors but routine screening is not recommended in international guidelines. The aim of our study was to determinate the prevalence of duodenal tumors in a French cohort of LS patients.

Methods

Patients carrying a germline pathogenic variant in a MMR gene, supported by our local network, in which at least one upper endoscopy had been performed, were included. We registered the occurrence of duodenal lesions in those patients.

Results

154 LS patients were identified including respectively 85 MSH2 and 41 MLH1 mutated patients respectively. Seven out of 154 (4.5%) had at least one duodenal lesion. Median age at diagnosis was 58 years (range: 49–73). The twelve lesions locations were: descending duodenum (n?=?7), genu inferius (n?=?2), duodenal bulb (n?=?1), ampulla (n?=?1), fourth duodenum (n?=?1). Three lesions were invasive adenocarcinomas. The incidence rate of duodenal lesions in patients with MSH2 or MLH1 pathogenic variants was respectively 7.1% (6 out of 85) and 2.4% (1 out of 41) emphasizing a trend toward increased risk of developing duodenal lesion in MSH2 mutated patients: OR: 5.17, IC95% (0.8–60.07), p?=?0.1307.

Conclusion

Regarding this high prevalence rate, especially in MSH2 patients, regular duodenal screening during upper endoscopy should be considered in routine in LS patients.  相似文献   
109.
Stigma is a widely used concept in social science research and an extensive literature claims that stigmatisation contributes to numerous negative health outcomes. However, few studies compare groups that vary in the extent to which they are stigmatised and even fewer studies examine stigma's independent and mediating effects. This article addresses these gaps in a comparative study of perceived stigma and drug use among three low‐income feminised service occupations: sex work, food and alcoholic beverage serving, and barbering and hairstyling. An analysis of longitudinal data shows positive associations between sex work, perceived stigma, and socially less acceptable drug use (for example, heroin and cocaine), and that stigma mediates part of the link between sex work and the use of these drugs. Our overall findings suggest that perceived stigma is pronounced among those who work in the sex industry and negatively affects health independently of sex work involvement.  相似文献   
110.

Background

Septic shock is associated with hypovolemia resulting in organs failure and poor prognosis. The first step in hemodynamic resuscitation relies on early fluid expansion. In this study, we describe qualitative and quantitative fluid resuscitation of septic shock initially managed in a pre-hospital setting by a mobile intensive care unit.

Methods

Patients with septic shock who received pre-hospital medical care were retrospectively analysed. Qualitative and quantitative fluid resuscitation performed in the pre-hospital setting were analysed. Applying the "grey zone" concept, we define 3 categories of fluid expansion indexed on ideal body weight (IBW): >20ml/kg, 10-20ml/kg and ?<?10ml/kg. The relationship between the pre-specified categories and mortality at day 28 were analyzed.

Results

Ninety-five patients were included. The origin of sepsis was mainly pulmonary (68%). Mortality reached 34%. Pre-hospital fluid expansion was performed using serum saline (98%) with a mean of 1158±559ml. An inversed linear relationship between pre-specified categories and mortality was observed. Using logistic regression model, significant association with mortality remained for fluid expansion indexed on IBW: p=0.02, ORa [CI95] = 0.93 [0.89-0.98]. For fluid expansion indexed on IBW?<?10ml/kg, the OR [CI95] was 4.03 [1.78-9.41] (p=0.005) whereas for fluid expansion indexed on IBW?>?20ml/kg, the OR [CI95] was 0.30 [0.13-0.66] (p=0.01).

Discussion

Pre-hospital fluid resuscitation in septic shock is mainly performed using crystalloids with quantitative fluid expansion lower than recommended. Low pre-hospital fluid expansion was associated with increased mortality. Further prospective studies are needed to evaluate the impact of optimized early fluid expansion on mortality in the prehospital management of septic shock.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号